Expanding treatment options for metastatic prostate cancer

N Engl J Med. 2011 May 26;364(21):2055-8. doi: 10.1056/NEJMe1102758.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Androstenes
  • Androstenols / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Humans
  • Male
  • Neoplasm Metastasis
  • Prednisone / therapeutic use
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / mortality
  • Receptors, Androgen / metabolism
  • Steroid 17-alpha-Hydroxylase / antagonists & inhibitors*

Substances

  • Androgen Antagonists
  • Androstenes
  • Androstenols
  • Receptors, Androgen
  • Steroid 17-alpha-Hydroxylase
  • abiraterone
  • Prednisone